DLA Piper publishes 2025 life sciences year in review

Categories: Hi-Tech

DLA Piper has released its 2025 Life Sciences Year in Review and What’s Ahead publication, analyzing major developments, challenges and opportunities shaping the global life sciences sector. The report reviews regulatory shifts, investment patterns and innovation trends that influenced the industry over the past year and sets out expectations for strategic priorities in 2026.

The commentary highlights continued growth drivers in biotech and pharmaceutical markets, evolving compliance landscapes, and the impact of emerging technologies on research and commercialization across regions.

Read DLA’s report here.

DLA Piper